FranΓ§aisπ See the interactive version (live chart) β
For Molina Healthcare, we replayed every analyst price target of the past 12 months and measured the real outcome: 48% were profitable, average return +9% (160 calls). At 3 months: +0% average return (41% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Morgan Stanley | 24 | 67% | +29% |
| B of A Securities | 13 | 38% | +7% |
| Wells Fargo | 13 | 23% | -11% |
| Jefferies | 11 | 46% | +9% |
| JP Morgan | 11 | 46% | +24% |
The analyst consensus on Molina Healthcare (MOH) is "Hold" (5 bullish, 7 bearish calls over 12 months). This is not advice: historically, 48% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $202 (+2% vs $199), ranging from $163 to $230 (11 analysts).
Over 1 year, 48% of analyst targets on Molina Healthcare were profitable, for an average return of +9% (across 160 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $202 within 12 months, i.e. +2% vs the current price. The most bullish targets $230, the most cautious $163.
Note: analyst targets are 12-month (median $202, +2%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (48%), and the stock's past trajectory.
Detailed valuation data for Molina Healthcare is available in the interactive analysis.
π See the full interactive analysis of Molina Healthcare β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.